In a human study, perindopril, an angiotensin-converting enzyme (ACE) inhibitor, reduced plasma ADMA levels in 11 non-insulin-dependent diabetes mellitus patients [93]. This evidence concerns the gene ACE and type 1 diabetes mellitus.